EACS 2017 ARV Therapies and Therapeutic Strategies

  EACS 17 Dinner Banner

Register Button EACS

About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 16th European AIDS Conference (EACS 2017). This program consists of five components: (1) EACS 2017 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) European Perspective on EACS 2017**: a 1.5 hour Case-based Internet symposium featuring Europe based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (3) Comprehensive Expert Review and Discussion of Key Presentations: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium (4) Rapid-Fire Review of EACS 2017: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (5) From Conference to Clinic: Reviewing and Applying Data From EACS 2017: case-based live meetings during which the key data are reviewed, discussed and applied to patient care.

From Conference to Clinic: Reviewing and Applying Data From EACS 2017 is an interactive, case-based dinner program series designed to highlight and discuss the clinical significance and application of new findings in HIV medicine presented at EACS 2017. Because the focus of the dinner programs will be on case studies and applying the data presented at EACS 2017 in a clinical setting, prior to attending a dinner program participants will be asked to view the CME Internet Symposium: EACS 2017 Expert Review, which will familiarize them with the EACS 2017 data and serve as a comprehensive conference overview and summary. As a result of this blended learning approach, participants will gain an increased understanding of key data presented at EACS 2017 and be better prepared to address their HIV patients' health needs and provide optimal care in a clinical setting.

All online components of the program will be accessible at www.viraled.com

This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EACS 2017 and it is not sanctioned by the organizers of EACS 2017. 

** The CME Internet Symposium: European Perspective on EACS 2017 component is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine and supported by an independent educational grant from ViiV Healthcare.

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Educational Objectives:

After completing this activity, the participant should be better able to:

  • Use data reported at EACS 2017 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities

  • Use in a clinical setting findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at EACS 2017
  • Employ strategies based on studies and data presented at EACS 2017 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care

  • Discuss with patients and colleagues the studies and data on therapies for HIV/AIDS presented at EACS 2017 and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS

Back to Top

Program Dates and Locations:

Tuesday, November 7, 2017
Phoenix, AZ
Wednesday, November 15, 2017
Chicago, IL

Wednesday, November 8, 2017
Newark, NJ

Wednesday, November 15, 2017
Oakland, CA

Thursday, November 9, 2017
Brooklyn, NY

Thursday, November 16, 2017
Jackson, MS

Thursday, November 9, 2017
Miami, FL
 Thursday, November 16, 2017
Washington, DC

  Tuesday, November 28, 2017
Houston, TX

Back to Top 

Schedule for All Programs:

6:00 - 6:30 PM: Check-in/Walk-in Registration

6:30 - 8:30 PM: Program and Q&A

Program Faculty:

Richard A. Elion, MD
Associate Professor of
Clinical Medicine
George Washington
University Medical Center
Washington, DC
 Jeff Burack, MD
Co-Medical Director
East Bay AIDS Center
Oakland, California
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at
the University of Pennsylvania
Philadelphia, Pennsylvania
Wilbert Jordan, MD
Medical Director
Charles Drew
Medical Center
Los Angeles, California
Renslow Sherer, MD
Professor of Medicine
Section of Infectious
Diseases and Global Health
University of Chicago
Chicago, Illinois
Back to Top  

Physician Continuing Medical Education:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest:

The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Back to Top

Sunshine Act:

As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.

Back to Top


VE logo 300px 


This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.


Prepare to print

Share this page:

Get link code to this page                     

Back to Top